<section xmlns="http://xml.house.gov/schemas/uslm/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" style="-uslm-lc:I80" id="id41d07c91-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523"><num value="1523">§ 1523.</num><heading> Definitions</heading>
<chapeau style="-uslm-lc:I11" class="indent0">In this subchapter:</chapeau><paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c92-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/1"><num value="1" class="bold">(1)</num><heading class="bold"> Administrator</heading><content><p style="-uslm-lc:I12" class="indent1">The term “Administrator” means the Administrator appointed by the Director under <ref href="/us/usc/t21/s1531/c">section 1531(c) of this title</ref>.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c93-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/2"><num value="2" class="bold">(2)</num><heading class="bold"> Advisory Commission</heading><content><p style="-uslm-lc:I12" class="indent1">The term “Advisory Commission” means the Advisory Commission established under section 1541 <ref class="footnoteRef" idref="fn002156">1</ref><note type="footnote" id="fn002156"><num>1</num> See References in Text note below.</note> of this title.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c94-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/3"><num value="3" class="bold">(3)</num><heading class="bold"> Community</heading><content><p style="-uslm-lc:I12" class="indent1">The term “community” shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c95-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/4"><num value="4" class="bold">(4)</num><heading class="bold"> Director</heading><content><p style="-uslm-lc:I12" class="indent1">The term “Director” means the Director of the Office of National Drug Control Policy.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c96-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/5"><num value="5" class="bold">(5)</num><heading class="bold"> Eligible coalition</heading><content><p style="-uslm-lc:I12" class="indent1">The term “eligible coalition” means a coalition that meets the applicable criteria under <ref href="/us/usc/t21/s1532/a">section 1532(a) of this title</ref>.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c97-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/6"><num value="6" class="bold">(6)</num><heading class="bold"> Grant recipient</heading><content><p style="-uslm-lc:I12" class="indent1">The term “grant recipient” means the recipient of a grant award under <ref href="/us/usc/t21/s1532">section 1532 of this title</ref>.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c98-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/7"><num value="7" class="bold">(7)</num><heading class="bold"> Nonprofit organization</heading><content><p style="-uslm-lc:I12" class="indent1">The term “nonprofit organization” means an organization described under <ref href="/us/usc/t26/s501/c/3">section 501(c)(3) of title 26</ref> that is exempt from taxation under <ref href="/us/usc/t26/s501/a">section 501(a) of title 26</ref>.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c99-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/8"><num value="8" class="bold">(8)</num><heading class="bold"> Program</heading><content><p style="-uslm-lc:I12" class="indent1">The term “Program” means the program established under <ref href="/us/usc/t21/s1531/a">section 1531(a) of this title</ref>.</p>
</content>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c9a-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/9"><num value="9" class="bold">(9)</num><heading class="bold"> Substance use and misuse</heading><chapeau>The term “substance use and misuse” means—</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="id41d07c9b-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/9/A"><num value="A">(A)</num><content> the illegal use or misuse of drugs, including substances for which a listing is effect <ref class="footnoteRef" idref="fn002157">2</ref><note type="footnote" id="fn002157"><num>2</num> So in original.</note> under any of schedules I through V under <ref href="/us/usc/t21/s812">section 812 of this title</ref>;</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="id41d07c9c-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/9/B"><num value="B">(B)</num><content> the misuse of inhalants or over-the-counter drugs; or</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="id41d07c9d-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/9/C"><num value="C">(C)</num><content> the use of alcohol, tobacco, or other related product as such use is prohibited by State or local law.</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I79" class="indent3 firstIndent-2" id="id41d07c9e-a3d3-11e9-95d4-f3ff9237185e" identifier="/us/usc/t21/s1523/10"><num value="10" class="bold">(10)</num><heading class="bold"> Youth</heading><content><p style="-uslm-lc:I12" class="indent1">The term “youth” shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission.</p>
</content>
</paragraph>
<sourceCredit id="id41d07c9f-a3d3-11e9-95d4-f3ff9237185e">(<ref href="/us/pl/100/690/tI/s1023">Pub. L. 100–690, title I, § 1023</ref>, as added <ref href="/us/pl/105/20/s2/a/2">Pub. L. 105–20, § 2(a)(2)</ref>, <date date="1997-06-27">June 27, 1997</date>, <ref href="/us/stat/111/225">111 Stat. 225</ref>; amended <ref href="/us/pl/115/271/tVIII/s8203/b/2">Pub. L. 115–271, title VIII, § 8203(b)(2)</ref>, <date date="2018-10-24">Oct. 24, 2018</date>, <ref href="/us/stat/132/4111">132 Stat. 4111</ref>.)</sourceCredit>
<notes type="uscNote" id="id41d07ca0-a3d3-11e9-95d4-f3ff9237185e">
<note style="-uslm-lc:I75" topic="referencesInText" id="id41d07ca1-a3d3-11e9-95d4-f3ff9237185e">
<heading class="centered smallCaps">References in Text</heading><p style="-uslm-lc:I21" class="indent0"><ref href="/us/usc/t21/s1541">Section 1541 of this title</ref>, referred to in par. (2), was repealed by <ref href="/us/pl/115/271/tVIII/s8203/b/5">Pub. L. 115–271, title VIII, § 8203(b)(5)</ref>, <date date="2018-10-24">Oct. 24, 2018</date>, <ref href="/us/stat/132/4112">132 Stat. 4112</ref>.</p>
</note>
<note style="-uslm-lc:I74" topic="amendments" id="id41d07ca2-a3d3-11e9-95d4-f3ff9237185e"><heading class="centered smallCaps">Amendments</heading><p style="-uslm-lc:I21" class="indent0">2018—Par. (9). <ref href="/us/pl/115/271">Pub. L. 115–271</ref>, which directed adding par. (9) and striking out former par. (9), which defined “substance abuse”, in section 1023 of “chapter 2 of subtitle A of title I of the National Narcotics Leadership Act of 1988”, was executed to this section, which is section 1023 of chapter 2 of the National Narcotics Leadership Act of 1988, to reflect the probable intent of Congress. The National Narcotics Leadership Act of 1988 is itself subtitle A of title I of <ref href="/us/pl/100/690">Pub. L. 100–690</ref>.</p>
</note>
</notes>
</section>